
  
    
      
        Background_NNP
        Since_IN the_DT beginning_NN of_IN the_DT acquired_VBN immunodeficiency_NN
        syndrome_NN (_( AIDS_NNP )_) epidemic_NN ,_, pulmonary_JJ complications_NNS have_VBP been_VBN
        major_JJ causes_NNS of_IN morbidity_NN and_CC mortality_NN in_IN patients_NNS with_IN
        human_JJ immunodeficiency_NN virus_NN (_( HIV_NNP )_) infection_NN [_NN 1_CD ]_NN ._. In_IN
        addition_NN to_TO the_DT common_JJ pulmonary_JJ diseases_NNS affecting_VBG
        immunocompetent_NN individuals_NNS ,_, HIV_NNP seropositive_JJ patients_NNS are_VBP
        prone_JJ to_TO other_JJ infectious_JJ and_CC noninfectious_JJ complications_NNS ._.
        The_DT types_NNS of_IN pulmonary_JJ complications_NNS that_WDT develop_VBP depend_VB on_IN
        the_DT degree_NN of_IN immunosuppression_NN ,_, HIV_NNP transmission_NN category_NN ,_,
        and_CC geographic_JJ location_NN ._. Antiretroviral_NNP therapy_NN and_CC 
        Pneumocystis_NNP carinii_NN pneumonia_NN (_( PCP_NNP )_)
        prophylaxis_NNS have_VBP improved_VBN the_DT clinical_JJ course_NN and_CC outcome_NN
        of_IN HIV-infected_NNP patients_NNS ._. However_RB ,_, pulmonary_JJ complications_NNS ,_,
        including_VBG PCP_NNP ,_, have_VBP remained_VBN common_JJ [_NN 2_CD ]_NN ._.
        The_DT Pulmonary_NNP Complications_NNP ,_, Intensive_NNP Care_NNP Unit_NNP
        Support_NN ,_, and_CC Prognostic_NNP Factors_NNP of_IN Hospitalized_NNP Patients_NNPS
        With_IN HIV_NNP (_( PIP_NNP )_) Study_NN is_VBZ a_DT single-center_JJ ,_, prospective_JJ
        observational_NN study_NN designed_VBN to_TO describe_VB the_DT types_NNS of_IN
        pulmonary_JJ complications_NNS and_CC the_DT role_NN of_IN critical_JJ care_NN
        support_NN and_CC to_TO determine_VB the_DT prognostic_JJ factors_NNS of_IN
        hospitalized_VBN HIV-infected_NNP adults_NNS ._. Knowledge_NNP of_IN the_DT types_NNS of_IN
        pulmonary_JJ complications_NNS in_IN patients_NNS with_IN HIV_NNP infection_NN will_MD
        help_VB clinicians_NNS to_TO develop_VB better_RBR diagnostic_JJ and_CC
        therapeutic_JJ approaches_NNS ._. This_DT article_NN describes_VBZ the_DT
        nonbacterial_NN pulmonary_JJ complications_NNS that_WDT were_VBD detected_VBN at_IN
        hospital_NN admission_NN and_CC during_IN hospitalization_NN of_IN 599_CD
        patients_NNS ._.
      
      
        Material_NNP and_CC Methods_NNP
        This_DT prospective_JJ ,_, observational_NN study_NN included_VBD 1_CD ,_, 225_CD
        consecutive_JJ hospital_NN admissions_NNS of_IN 599_CD adults_NNS with_IN HIV_NNP
        infection_NN ._. The_DT patients_NNS were_VBD identified_VBN from_IN the_DT hospital_NN 's_POS
        computer_NN system_NN and_CC admission_NN logbooks_NNS and_CC by_IN contacting_VBG
        the_DT case_NN manager_NN for_IN patients_NNS with_IN HIV_NNP ._. Patients_NNS 17_CD years_NNS
        or_CC older_JJR with_IN confirmed_VBD HIV_NNP infection_NN were_VBD included_VBN in_IN the_DT
        study_NN ._. All_DT the_DT patients_NNS were_VBD treated_VBN at_IN the_DT University_NNP
        Medical_NNP Center_NNP ,_, Jacksonville_NNP ,_, Florida_NNP ,_, during_IN the_DT 3_CD years_NNS
        from_IN April_NNP 1_CD ,_, 1995_CD ,_, through_IN March_NNP 31_CD ,_, 1998_CD ._. The_DT University_NNP
        Medical_NNP Center_NNP is_VBZ a_DT 528_CD -_: bed_NN ,_, teaching_NN ,_, inner-city_JJ hospital_NN
        affiliated_VBN with_IN the_DT University_NNP of_IN Florida_NNP ._. The_DT study_NN was_VBD
        approved_VBN by_IN the_DT Institutional_NNP Review_NNP Board_NNP of_IN the_DT hospital_NN ,_,
        which_WDT waived_VBD the_DT need_NN for_IN informed_VBN consent_NN ._.
        Data_NNP were_VBD collected_VBN on_IN age_NN ,_, sex_NN ,_, race_NN ,_, exposure_NN category_NN
        for_IN HIV_NNP infection_NN ,_, CD_NNP 4_CD +_NN lymphocyte_NN count_NN ,_, APACHE_NNP (_( Acute_NNP
        Physiology_NNP and_CC Chronic_NNP Health_NNP Evaluation_NNP )_) II_NNP score_NN ,_,
        hospital_NN stay_NN ,_, and_CC in-hospital_JJ mortality_NN ._. The_DT investigator_NN ,_,
        a_DT pulmonologist_NN ,_, reviewed_VBD all_DT chest_NN radiographs_NNS ._. All_DT
        nonbacterial_NN pulmonary_JJ complications_NNS that_WDT were_VBD diagnosed_VBN
        during_IN patients_NNS '_POS hospital_NN stays_NNS were_VBD noted_VBN ._. The_DT
        microbiologic_JJ ,_, cytologic_JJ ,_, and_CC histologic_JJ findings_NNS of_IN
        expectorated_JJ and_CC induced_VBN sputum_NN and_CC other_JJ samples_NNS obtained_VBN
        by_IN bronchoscopy_NN ,_, mediastinoscopy_NN ,_, and_CC thoracotomy_NN were_VBD
        noted_VBN ._.
        Only_RB confirmed_VBD pulmonary_JJ complications_NNS were_VBD included_VBN ._. 
        P_NN carinii_NN ,_, mycobacterial_NN ,_, fungal_NN ,_,
        and_CC viral_JJ pulmonary_JJ infections_NNS were_VBD diagnosed_VBN by_IN
        identifying_VBG the_DT organisms_NNS in_IN stains_NNS or_CC cultures_NNS of_IN sputum_NN ,_,
        bronchial_NN washing_NN ,_, bronchoalveolar_NN lavage_NN (_( BAL_NNP )_) ,_, and_CC lung_NN
        tissue_NN ._. Multiple_NNP episodes_NNS of_IN PCP_NNP and_CC mycobacterial_NN
        infections_NNS were_VBD defined_VBN by_IN identifying_VBG the_DT same_JJ organism_NN on_IN
        different_JJ admissions_NNS of_IN the_DT same_JJ patient_NN ._. Fungus_NNP ball_NN was_VBD
        diagnosed_VBN by_IN the_DT typical_JJ chest_NN radiographic_JJ finding_NN of_IN a_DT
        fungus_NN ball_NN in_IN a_DT preexisting_VBG cavity_NN ._. Acute_NNP asthma_NN
        exacerbation_NN ,_, acute_JJ exacerbation_NN of_IN chronic_JJ obstructive_JJ
        pulmonary_JJ disease_NN (_( COPD_NNP )_) ,_, and_CC cardiogenic_JJ pulmonary_JJ edema_NN
        were_VBD diagnosed_VBN by_IN physical_JJ findings_NNS in_IN the_DT appropriate_JJ
        clinical_JJ setting_NN ._. Pulmonary_NNP embolism_NN was_VBD documented_VBN by_IN
        pulmonary_JJ angiogram_NN or_CC spiral_NN computed_JJ tomography_NN of_IN the_DT
        chest_NN ._. Pulmonary_NNP contusion_NN was_VBD diagnosed_VBN by_IN the_DT development_NN
        of_IN radiographic_JJ densities_NNS of_IN the_DT chest_NN following_VBG chest_NN
        trauma_NN ._. Pulmonary_NNP sarcoidosis_NNS and_CC malignancies_NNS were_VBD
        diagnosed_VBN by_IN bronchoscopy_NN ._. In_IN patients_NNS with_IN 
        Mycobacterium_NNP tuberculosis_NNS (_( MTB_NNP )_)
        infection_NN ,_, antibiotic_JJ susceptibility_NN test_NN results_NNS were_VBD
        reviewed_VBN ._.
        For_IN the_DT purpose_NN of_IN this_DT study_NN ,_, multiple_JJ hospital_NN
        admissions_NNS of_IN the_DT same_JJ patient_NN were_VBD analyzed_VBN independently_RB
        of_IN each_DT other_JJ ._. StatView_NNP 5_CD ._. 0_CD computer_NN software_NN (_( SAS_NNP
        Institute_NNP Inc_NNP ._. ,_, Cary_NNP ,_, NC_NNP )_) was_VBD used_VBN for_IN statistical_JJ
        analysis_NN ._. All_DT means_NNS were_VBD expressed_VBN with_IN their_PRP$ standard_JJ
        deviations_NNS (_( SDs_NNP )_) ._. Comparisons_NNP between_IN groups_NNS were_VBD made_VBN by_IN
        using_VBG the_DT Student_NNP 
        t_NN ,_, Mann-_NNP Whitney_NNP U_NNP ,_, Χ_NN 2_CD ,_, and_CC Fisher_NNP
        exact_JJ tests_NNS ._. 
        P_NN values_NNS <_NN 0_CD ._. 05_CD were_VBD considered_VBN
        significant_JJ ._. Continuity_NNP correction_NN was_VBD used_VBN to_TO determine_VB
        the_DT 
        P_NN values_NNS of_IN Χ_NN 2_CD tests_NNS ._. The_DT
        sensitivity_NN ,_, specificity_NN ,_, and_CC positive_JJ and_CC negative_JJ
        predictive_JJ values_NNS of_IN lactate_NN dehydrogenase_NN (_( LDH_NNP )_) for_IN the_DT
        diagnosis_NN of_IN PCP_NNP were_VBD calculated_VBN by_IN using_VBG the_DT normal_JJ high_JJ
        serum_NN LDH_NNP level_NN for_IN our_PRP$ laboratory_NN of_IN 210_CD units_NNS /_NN mL_NN as_IN a_DT
        cutoff_NN point_NN ._.
      
      
        Results_NNS
        Demographic_NNP characteristics_NNS ,_, exposure_NN categories_NNS ,_, CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN ,_, and_CC APACHE_NNP II_NNP scores_NNS of_IN the_DT hospital_NN
        admissions_NNS are_VBP listed_VBN in_IN Table_NNP 1_CD ._. The_DT primary_JJ reason_NN for_IN
        hospitalization_NN was_VBD pulmonary_JJ in_IN 356_CD of_IN the_DT 1_CD ,_, 225_CD hospital_NN
        admissions_NNS (_( 29_CD %_NN )_) ._. The_DT nonbacterial_NN pulmonary_JJ complications_NNS
        observed_VBD during_IN the_DT study_NN are_VBP listed_VBN in_IN Table_NNP 2_CD ._. The_DT median_JJ
        APACHE_NNP II_NNP score_NN of_IN patients_NNS with_IN PCP_NNP ,_, MTB_NNP ,_, and_CC 
        M_NNP avium_NN complex_JJ (_( MAC_NNP )_) were_VBD 13_CD ,_, 15_CD ,_,
        and_CC 16_CD ,_, respectively_RB ._.
        PCP_NNP was_VBD diagnosed_VBN in_IN 85_CD (_( 7_CD %_NN )_) of_IN the_DT 1_CD ,_, 225_CD hospital_NN
        admissions_NNS (_( 78_CD patients_NNS )_) ._. Seventeen_CD of_IN the_DT 345_CD admissions_NNS
        (_( 5_CD %_NN )_) during_IN the_DT first_JJ year_NN of_IN the_DT study_NN had_VBD PCP_NNP compared_VBD
        with_IN 29_CD of_IN 435_CD admissions_NNS (_( 7_CD %_NN )_) during_IN the_DT second_JJ and_CC 39_CD of_IN
        445_CD admissions_NNS (_( 9_CD %_NN )_) during_IN the_DT third_JJ period_NN (_( 
        P_NN =_SYM 0_CD ._. 1050_CD )_) ._. Two_CD episodes_NNS of_IN PCP_NNP were_VBD
        diagnosed_VBN in_IN 7_CD and_CC a_DT single_JJ episode_NN in_IN 71_CD patients_NNS during_IN
        the_DT study_NN ._. In_IN the_DT 7_CD patients_NNS who_WP had_VBD 2_CD episodes_NNS of_IN PCP_NNP ,_, the_DT
        time_NN between_IN the_DT episodes_NNS ranged_VBD from_IN 2_CD to_TO 24_CD months_NNS ._.
        Induced_NNP sputum_NN from_IN 288_CD hospital_NN admissions_NNS and_CC BAL_NNP from_IN 69_CD
        hospital_NN admissions_NNS were_VBD examined_VBN for_IN 
        P_NN carinii_NN by_IN using_VBG monoclonal_NN
        antibodies_NNS ._. The_DT methods_NNS used_VBN to_TO diagnose_NN PCP_NNP are_VBP listed_VBN in_IN
        Table_NNP 3_CD ._. Seventy-seven_NNP of_IN the_DT 85_CD hospital_NN admissions_NNS with_IN
        PCP_NNP had_VBD induced_VBN sputum_NN examined_VBD for_IN 
        P_NN carinii_NN ;_: 62_CD (_( 81_CD %_NN )_) were_VBD positive_JJ ._.
        PCP_NNP was_VBD diagnosed_VBN by_IN BAL_NNP in_IN 15_CD hospital_NN admissions_NNS with_IN
        negative_JJ findings_NNS from_IN induced_VBN sputum_NN ._. Induced_NNP sputum_NN was_VBD
        diagnostic_JJ of_IN PCP_NNP in_IN 2_CD patients_NNS whose_WP$ BAL_NNP results_NNS were_VBD
        negative_JJ ._. 
        P_NN carinii_NN involved_VBD a_DT cervical_JJ lymph_NN
        node_NN in_IN 1_CD patient_NN ._.
        Serum_NNP LDH_NNP was_VBD measured_VBN in_IN 200_CD hospital_NN admissions_NNS in_IN
        which_WDT the_DT primary_JJ diagnosis_NN was_VBD pneumonia_NN :_: 57_CD PCP_NNP and_CC 143_CD
        non-_NN PCP_NNP ._. Among_IN these_DT 200_CD hospital_NN admissions_NNS ,_, the_DT
        sensitivity_NN ,_, specificity_NN ,_, and_CC negative_JJ and_CC positive_JJ
        predictive_JJ values_NNS of_IN serum_NN LDH_NNP in_IN the_DT diagnosis_NN of_IN PCP_NNP were_VBD
        98_CD %_NN ,_, 31_CD %_NN ,_, 98_CD %_NN ,_, and_CC 36_CD %_NN ,_, respectively_RB ._.
        The_DT initial_JJ chest_NN radiograph_NN obtained_VBN at_IN hospital_NN
        admission_NN showed_VBD no_DT infiltrate_VB in_IN 5_CD ,_, focal_JJ infiltrate_VB in_IN 7_CD ,_,
        and_CC diffuse_NN infiltrate_VB in_IN 73_CD of_IN the_DT 85_CD hospital_NN admissions_NNS
        with_IN PCP_NNP ._. The_DT differences_NNS in_IN CD_NNP 4_CD +_NN lymphocyte_NN count_NN ,_,
        duration_NN of_IN hospital_NN stay_NN ,_, and_CC mortality_NN of_IN patients_NNS with_IN
        and_CC without_IN PCP_NNP are_VBP listed_VBN in_IN Table_NNP 4_CD ._. The_DT CD_NNP 4_CD +_NN lymphocyte_NN
        count_NN of_IN 5_CD patients_NNS with_IN PCP_NNP was_VBD >_NN 200_CD /_NN μL_NN ._. Pulmonary_NNP
        mycobacterial_NN coinfection_NN was_VBD identified_VBN in_IN 18_CD of_IN the_DT 85_CD
        hospital_NN admissions_NNS with_IN PCP_NNP (_( 21_CD %_NN )_) ._. Cytomegalovirus_NNP (_( CMV_NNP )_)
        was_VBD isolated_VBN from_IN the_DT BAL_NNP of_IN 7_CD hospital_NN admissions_NNS with_IN
        PCP_NNP ._.
        Mycobacteria_NNP were_VBD isolated_VBN from_IN the_DT respiratory_JJ specimen_NN
        of_IN 115_CD hospital_NN admissions_NNS ._. The_DT frequency_NN of_IN acid-fast_JJ
        bacilli_NN (_( AFB_NNP )_) smear_NN in_IN culture-positive_JJ MTB_NNP and_CC MAC_NNP
        respiratory_JJ infection_NN is_VBZ listed_VBN in_IN Table_NNP 5_CD ._. Multiple_NNP
        episodes_NNS of_IN pulmonary_JJ mycobacterial_NN infections_NNS were_VBD
        diagnosed_VBN in_IN 11_CD patients_NNS during_IN the_DT 3_CD -_: year_NN study_NN :_: 3_CD
        episodes_NNS of_IN pulmonary_JJ tuberculosis_NNS in_IN 1_CD patient_NN and_CC 2_CD
        episodes_NNS in_IN 3_CD patients_NNS ;_: 5_CD episodes_NNS of_IN pulmonary_JJ MAC_NNP in_IN 2_CD
        patients_NNS ,_, 3_CD in_IN 1_CD patient_NN ,_, and_CC 2_CD in_IN 3_CD patients_NNS ;_: and_CC 2_CD
        episodes_NNS of_IN pulmonary_JJ 
        M_NNP kansasii_NN in_IN 1_CD patient_NN ._. The_DT time_NN
        between_IN the_DT different_JJ episodes_NNS ranged_VBD from_IN 2_CD weeks_NNS to_TO 2_CD
        years_NNS ._. MTB_NNP was_VBD isolated_VBN from_IN respiratory_JJ specimens_NNS in_IN 40_CD
        hospital_NN admissions_NNS of_IN 35_CD patients_NNS ._. Thirteen_CD of_IN the_DT 345_CD
        admissions_NNS (_( 4_CD %_NN )_) during_IN the_DT first_JJ year_NN of_IN the_DT study_NN had_VBD
        respiratory_JJ MTB_NNP infection_NN compared_VBN with_IN 13_CD of_IN 435_CD
        admissions_NNS (_( 3_CD %_NN )_) during_IN the_DT second_JJ and_CC 14_CD of_IN 445_CD admissions_NNS
        (_( 3_CD %_NN )_) during_IN the_DT third_JJ period_NN (_( 
        P_NN =_SYM 0_CD ._. 8180_CD )_) ._. All_DT the_DT MTB_NNP isolates_VBZ
        were_VBD sensitive_JJ to_TO isoniazid_NN ._. Rifampin_NNP resistance_NN developed_VBN
        in_IN 1_CD patient_NN during_IN the_DT second_JJ episode_NN of_IN MTB_NNP
        infection_NN ._.
        MAC_NNP was_VBD isolated_VBN from_IN respiratory_JJ specimens_NNS in_IN 51_CD
        hospital_NN admissions_NNS of_IN 38_CD patients_NNS ._. Eighteen_CD of_IN the_DT 345_CD
        admissions_NNS (_( 5_CD %_NN )_) during_IN the_DT first_JJ year_NN of_IN the_DT study_NN had_VBD
        respiratory_JJ MAC_NNP infection_NN compared_VBN with_IN 16_CD of_IN 435_CD
        admissions_NNS (_( 4_CD %_NN )_) during_IN the_DT second_JJ and_CC 17_CD of_IN 445_CD admissions_NNS
        (_( 4_CD %_NN )_) during_IN the_DT third_JJ period_NN (_( 
        P_NN =_SYM 0_CD ._. 5095_CD )_) ._. Lung_NNP tissue_NN confirming_VBG
        the_DT diagnosis_NN was_VBD obtained_VBN in_IN only_RB 1_CD of_IN the_DT patients_NNS with_IN
        MAC_NNP ._. 
        M_NNP gordonae_NN was_VBD isolated_VBN from_IN
        respiratory_JJ specimens_NNS in_IN 11_CD hospital_NN admissions_NNS of_IN 11_CD
        patients_NNS and_CC 
        M_NNP kansasii_NN in_IN 10_CD hospital_NN admissions_NNS
        of_IN 9_CD patients_NNS ._. Nontuberculous_NNP mycobacteria_NN were_VBD identified_VBN
        in_IN 3_CD patients_NNS ._.
        The_DT median_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN in_IN the_DT hospital_NN
        admissions_NNS with_IN MTB_NNP was_VBD 94_CD /_NN μL_NN compared_VBN with_IN 10_CD /_NN μL_NN in_IN those_DT
        with_IN MAC_NNP (_( 
        P_NN <_NN 0_CD ._. 0001_CD )_) ._. The_DT initial_JJ chest_NN
        radiograph_NN at_IN hospital_NN admission_NN showed_VBD no_DT infiltrate_VB in_IN 10_CD
        hospital_NN admissions_NNS with_IN pulmonary_JJ MTB_NNP and_CC in_IN 17_CD hospital_NN
        admissions_NNS with_IN pulmonary_JJ MAC_NNP ._. The_DT extrapulmonary_JJ sites_NNS
        from_IN which_WDT MTB_NNP and_CC MAC_NNP were_VBD isolated_VBN are_VBP listed_VBN in_IN Table_NNP 5_CD ._.
        The_DT in-hospital_JJ case-fatality_JJ rate_NN of_IN hospital_NN admissions_NNS
        with_IN pulmonary_JJ MTB_NNP was_VBD 5_CD %_NN (_( 2_CD of_IN 40_CD )_) compared_VBN with_IN 6_CD %_NN (_( 3_CD of_IN
        51_CD )_) of_IN those_DT with_IN pulmonary_JJ MAC_NNP (_( 
        P_NN >_NN 0_CD ._. 9999_CD )_) ._.
        Viral_NNP infections_NNS were_VBD detected_VBN in_IN the_DT BAL_NNP in_IN 13_CD hospital_NN
        admissions_NNS among_IN 13_CD different_JJ patients_NNS :_: CMV_NNP in_IN 10_CD ,_,
        respiratory_JJ syncytial_NN virus_NN in_IN 1_CD ,_, herpes_NNS simplex_NN virus_NN in_IN
        1_CD ,_, and_CC influenza_NN B_NNP virus_NN in_IN 1_CD ._. Of_IN the_DT 13_CD hospital_NN
        admissions_NNS with_IN viral_JJ infection_NN ,_, only_RB 1_CD patient_NN ,_, who_WP had_VBD
        CMV_NNP ,_, died_VBD ._. Pulmonary_NNP involvement_NN by_IN 
        Nocardia_NNP asteroides_NNS was_VBD seen_VBN in_IN 3_CD
        patients_NNS ,_, none_NN of_IN whom_WP died_VBD ._. Fungus_NNP ball_NN was_VBD seen_VBN on_IN the_DT
        chest_NN radiograph_NN of_IN 2_CD patients_NNS ,_, 1_CD of_IN whom_WP died_VBD ._. Pulmonary_NNP
        histoplasmosis_NNS was_VBD diagnosed_VBN in_IN a_DT patient_NN of_IN South_JJ American_JJ
        origin_NN who_WP died_VBD during_IN hospitalization_NN ._.
        Malignancies_NNP involving_VBG the_DT lungs_NNS were_VBD detected_VBN in_IN 6_CD
        hospital_NN admissions_NNS of_IN 6_CD different_JJ patients_NNS :_: 2_CD bronchogenic_JJ
        carcinoma_NN ,_, 2_CD non-_NN Hodgkin_NNP lymphoma_NN ,_, 1_CD Hodgkin_NNP lymphoma_NN ,_, and_CC
        1_CD Kaposi_NNP sarcoma_NN ._. The_DT 2_CD patients_NNS with_IN bronchogenic_JJ
        carcinoma_NN were_VBD 48_CD -_: and_CC 52_CD -_: year-old_JJ African-_NNP American_JJ men_NNS who_WP
        smoked_VBD cigarettes_NNS ._. The_DT risk_NN factor_NN for_IN HIV_NNP transmission_NN was_VBD
        homosexuality_NN in_IN 1_CD patient_NN with_IN small_JJ cell_NN cancer_NN and_CC
        injection_NN drug_NN use_NN in_IN the_DT other_JJ patient_NN with_IN squamous_JJ cell_NN
        cancer_NN ._. Of_IN the_DT 6_CD patients_NNS with_IN malignancy_NN ,_, only_RB 1_CD ,_, who_WP had_VBD
        Hodgkin_NNP lymphoma_NN ,_, died_VBD in_IN the_DT hospital_NN ._. All_DT 3_CD patients_NNS with_IN
        pulmonary_JJ sarcoidosis_NNS were_VBD of_IN African-_NNP American_JJ origin_NN and_CC
        survived_VBD to_TO hospital_NN dismissal_NN ._. Ten_CD patients_NNS were_VBD
        hospitalized_VBN for_IN acute_JJ asthma_NN attack_NN ,_, and_CC all_DT survived_VBD to_TO
        hospital_NN dismissal_NN ._. Of_IN the_DT patients_NNS admitted_VBN for_IN
        cardiogenic_JJ pulmonary_JJ edema_NN ,_, pulmonary_JJ embolism_NN ,_, acute_JJ
        exacerbation_NN of_IN COPD_NNP ,_, and_CC traumatic_JJ pulmonary_JJ contusion_NN ,_,
        only_RB 1_CD patient_NN ,_, who_WP had_VBD cardiogenic_JJ pulmonary_JJ edema_NN ,_, died_VBD
        before_IN hospital_NN dismissal_NN ._.
      
      
        Discussion_NNP
        This_DT study_NN describes_VBZ the_DT nonbacterial_NN pulmonary_JJ
        complications_NNS detected_VBD among_IN 1_CD ,_, 225_CD hospital_NN admissions_NNS of_IN
        599_CD adult_NN patients_NNS with_IN HIV_NNP infection_NN ._. The_DT study_NN population_NN
        consisted_VBD predominantly_RB of_IN African_NNP Americans_NNPS ,_, with_IN a_DT
        significant_JJ number_NN of_IN heterosexual_NN and_CC unidentified_JJ
        transmission_NN categories_NNS ._. The_DT HIV_NNP transmission_NN category_NN
        influences_VBZ the_DT types_NNS of_IN pulmonary_JJ complications_NNS that_WDT
        develop_VBP in_IN patients_NNS with_IN HIV_NNP ._. Because_IN homosexuality_NN and_CC
        injection_NN drug_NN use_NN are_VBP the_DT major_JJ HIV_NNP transmission_NN
        categories_NNS in_IN the_DT United_NNP States_NNPS ,_, the_DT findings_NNS in_IN our_PRP$ study_NN
        may_MD not_RB apply_VB to_TO other_JJ countries_NNS ._.
        PCP_NNP was_VBD the_DT most_RBS common_JJ nonbacterial_NN pulmonary_JJ
        complication_NN caused_VBN by_IN a_DT single_JJ organism_NN in_IN our_PRP$ study_NN ._.
        Despite_IN its_PRP$ decline_NN as_IN a_DT result_NN of_IN widespread_JJ
        antiretroviral_NN therapy_NN and_CC chemoprophylaxis_NNS ,_, PCP_NNP has_VBZ
        remained_VBN a_DT common_JJ complication_NN in_IN patients_NNS with_IN HIV_NNP
        infection_NN [_NN 2_CD 3_CD ]_NN ._. In_IN a_DT prospective_JJ multicenter_NN study_NN of_IN
        HIV_NNP seropositive_JJ patients_NNS ,_, for_IN 79_CD %_NN of_IN those_DT with_IN a_DT CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN <_NN 200_CD /_NN μL_NN receiving_VBG PCP_NNP
        chemoprophylaxis_NNS ,_, the_DT rate_NN of_IN first_JJ episode_NN PCP_NNP was_VBD 3_CD ._. 3_CD per_IN
        100_CD person-years_JJ [_NN 4_CD ]_NN ._. Although_IN actual_JJ data_NNS were_VBD not_RB
        available_JJ ,_, high_JJ rates_NNS of_IN noncompliance_NN with_IN and_CC lack_NN of_IN
        access_NN to_TO antiretroviral_NN therapy_NN and_CC chemoprophylaxis_NNS were_VBD
        likely_JJ in_IN our_PRP$ study_NN population_NN ,_, which_WDT included_VBD a_DT
        significant_JJ number_NN of_IN medically_RB underserved_JJ patients_NNS
        without_IN perceived_VBN risk_NN for_IN HIV_NNP ._.
        Previous_JJ studies_NNS addressed_VBD the_DT need_NN for_IN simpler_JJR tests_NNS
        and_CC strategies_NNS to_TO identify_VB patients_NNS with_IN a_DT high_JJ probability_NN
        of_IN having_VBG PCP_NNP to_TO initiate_VB either_CC empiric_JJ treatment_NN or_CC
        aggressive_JJ investigation_NN [_NN 5_CD 6_CD ]_NN ._. These_DT studies_NNS reported_VBD
        that_IN an_DT increase_NN in_IN LDH_NNP value_NN had_VBD variable_JJ specificity_NN and_CC
        sensitivity_NN for_IN the_DT diagnosis_NN of_IN PCP_NNP ._. HIV_NNP seropositive_JJ
        patients_NNS are_VBP at_IN increased_VBN risk_NN for_IN PCP_NNP when_WRB their_PRP$ CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN is_VBZ <_NN 200_CD /_NN μL_NN ._. Similar_JJ to_TO the_DT
        multicenter_NN study_NN by_IN the_DT Pulmonary_NNP Complications_NNP of_IN HIV_NNP
        Infection_NNP Study_NNP Group_NNP [_NN 4_CD ]_NN ,_, 94_CD %_NN of_IN the_DT patients_NNS with_IN PCP_NNP
        had_VBD a_DT CD_NNP 4_CD +_NN lymphocyte_NN count_NN <_NN 200_CD /_NN μL_NN in_IN the_DT PIP_NNP study_NN ._.
        The_DT classic_JJ chest_NN radiographic_JJ findings_NNS of_IN patients_NNS with_IN
        PCP_NNP include_VBP bilateral_JJ diffuse_NN opacities_NNS [_NN 7_CD ]_NN ._. However_RB ,_,
        some_DT patients_NNS present_JJ with_IN unusual_JJ chest_NN radiographic_JJ
        findings_NNS [_NN 7_CD 8_CD ]_NN ._. In_IN a_DT multicenter_NN study_NN from_IN the_DT United_NNP
        States_NNPS ,_, the_DT in-hospital_JJ mortality_NN rate_NN of_IN hospitalized_VBN
        patients_NNS with_IN cytologically_RB confirmed_VBD PCP_NNP was_VBD 14_CD %_NN [_NN 9_CD ]_NN ._.
        The_DT PIP_NNP study_NN showed_VBD that_IN PCP_NNP is_VBZ unusual_JJ in_IN patients_NNS with_IN
        normal_JJ CD_NNP 4_CD +_NN lymphocyte_NN count_NN and_CC serum_NN LDH_NNP concentration_NN ,_,
        can_MD present_VB with_IN atypical_JJ chest_NN radiographic_JJ findings_NNS ,_, can_MD
        be_VB diagnosed_VBN from_IN induced_VBN sputum_NN in_IN most_JJS of_IN the_DT cases_NNS ,_, and_CC
        is_VBZ associated_VBN with_IN 11_CD %_NN mortality_NN ._.
        In_IN the_DT PIP_NNP study_NN of_IN predominantly_RB African-_NNP American_JJ
        patients_NNS ,_, nearly_RB 50_CD %_NN of_IN the_DT MTB_NNP isolates_VBZ had_VBD a_DT negative_JJ AFB_NNP
        smear_NN ,_, none_NN of_IN the_DT isolates_VBZ was_VBD isoniazid_NN resistant_JJ ,_, and_CC
        25_CD %_NN of_IN the_DT admissions_NNS with_IN MTB_NNP respiratory_JJ infection_NN had_VBD no_DT
        infiltrate_VB on_IN the_DT initial_JJ chest_NN radiograph_NN ._. HIV-infected_NNP
        individuals_NNS are_VBP highly_RB susceptible_JJ to_TO contracting_NN
        tuberculous_JJ infection_NN and_CC are_VBP prone_JJ to_TO rapid_JJ evolution_NN of_IN
        active_JJ disease_NN [_NN 10_CD ]_NN ._. The_DT rate_NN of_IN tuberculosis_NNS is_VBZ high_JJ in_IN
        African_NNP Americans_NNPS and_CC in_IN injection_NN drug_NN users_NNS [_NN 11_CD ]_NN ._.
        Although_IN the_DT prevalence_NN of_IN a_DT positive_JJ AFB_NNP smear_NN in_IN patients_NNS
        with_IN pulmonary_JJ MTB_NNP is_VBZ approximately_RB the_DT same_JJ in_IN
        HIV-infected_NNP and_CC noninfected_JJ individuals_NNS ,_, it_PRP may_MD decline_VB in_IN
        advanced_VBD HIV-mediated_NNP immunosuppression_NN [_NN 12_CD ]_NN ._. A_DT previous_JJ
        study_NN of_IN 133_CD HIV-infected_NNP adults_NNS with_IN pulmonary_JJ MTB_NNP showed_VBD
        14_CD %_NN of_IN them_PRP had_VBD a_DT normal_JJ chest_NN radiograph_NN [_NN 13_CD ]_NN ._.
        The_DT isolation_NN of_IN MAC_NNP in_IN BAL_NNP or_CC sputum_NN does_VBZ not_RB
        distinguish_VB between_IN disease_NN and_CC colonization_NN ._. Prospective_JJ
        cohort_NN studies_NNS have_VBP shown_VBN that_IN in_IN 25_CD %_NN to_TO 35_CD %_NN of_IN patients_NNS
        with_IN HIV_NNP infection_NN disseminated_VBN MAC_NNP disease_NN eventually_RB
        develops_VBZ [_NN 14_CD 15_CD ]_NN ._. The_DT risk_NN of_IN disseminated_VBN MAC_NNP disease_NN
        depends_VBZ on_IN the_DT severity_NN of_IN the_DT immunodeficiency_NN ._. In_IN the_DT PIP_NNP
        study_NN ,_, patients_NNS with_IN MAC_NNP respiratory_JJ isolates_VBZ had_VBD a_DT low_JJ CD_NNP 4_CD
        +_NN lymphocyte_NN count_NN ,_, and_CC the_DT majority_NN of_IN them_PRP had_VBD evidence_NN of_IN
        disseminated_VBN disease_NN ._.
        CMV_NNP is_VBZ the_DT most_RBS common_JJ opportunistic_JJ viral_JJ infection_NN in_IN
        patients_NNS with_IN HIV_NNP [_NN 16_CD ]_NN ._. Although_IN CMV_NNP was_VBD isolated_VBN from_IN
        the_DT BAL_NNP of_IN 10_CD patients_NNS in_IN the_DT PIP_NNP study_NN ,_, its_PRP$ isolation_NN does_VBZ
        not_RB distinguish_VB between_IN infection_NN and_CC colonization_NN ._. Fungal_NNP
        infections_NNS are_VBP common_JJ in_IN patients_NNS with_IN HIV_NNP infection_NN ._.
        HIV-infected_NNP individuals_NNS residing_VBG in_IN areas_NNS endemic_JJ for_IN 
        Histoplasma_NNP capsulatum_NN are_VBP at_IN
        increased_VBN risk_NN for_IN 
        H_NNP capsulatum_NN infection_NN [_NN 17_CD ]_NN ._.
        Histoplasmosis_NNP is_VBZ uncommon_JJ in_IN individuals_NNS from_IN areas_NNS in_IN
        which_WDT 
        H_NNP capsulatum_NN is_VBZ nonendemic_JJ and_CC
        usually_RB represents_VBZ reactivation_NN [_NN 18_CD ]_NN ._. The_DT PIP_NNP study_NN was_VBD
        performed_VBN in_IN an_DT area_NN in_IN which_WDT 
        H_NNP capsulatum_NN is_VBZ nonendemic_JJ ,_, and_CC there_EX
        was_VBD only_RB 1_CD case_NN of_IN pulmonary_JJ histoplasmosis_NNS in_IN a_DT patient_NN
        who_WP had_VBD resided_VBN in_IN an_DT area_NN endemic_JJ for_IN 
        H_NNP capsulatum_NN ._. Although_IN the_DT lungs_NNS are_VBP
        the_DT primary_JJ site_NN of_IN cryptococcal_NN infection_NN ,_, pulmonary_JJ
        disease_NN was_VBD believed_VBN to_TO be_VB uncommon_JJ in_IN patients_NNS with_IN AIDS_NNP [_NN
        19_CD ]_NN ._. No_DT pulmonary_JJ cryptococcal_NN disease_NN was_VBD diagnosed_VBN in_IN
        the_DT PIP_NNP study_NN ._. However_RB ,_, a_DT recent_JJ review_NN of_IN 48_CD autopsies_NNS of_IN
        HIV-infected_NNP patients_NNS from_IN the_DT same_JJ institution_NN showed_VBD
        cryptococcal_NN pneumonia_NN to_TO be_VB as_RB frequent_JJ as_IN PCP_NNP [_NN 20_CD ]_NN
        ._.
        In_IN patients_NNS with_IN HIV_NNP infection_NN ,_, about_IN 20_CD %_NN are_VBP expected_VBN
        to_TO develop_VB a_DT malignancy_NN [_NN 21_CD ]_NN ._. The_DT PIP_NNP study_NN population_NN
        is_VBZ predominantly_RB African_NNP American_NNP ._. Blacks_NNS with_IN HIV_NNP
        infection_NN have_VBP a_DT lower_JJR risk_NN of_IN cancer_NN developing_VBG than_IN
        nonblacks_NNS [_NN 22_CD ]_NN ._. Kaposi_NNP sarcoma_NN and_CC non-_NN Hodgkin_NNP lymphoma_NN
        are_VBP the_DT most_RBS common_JJ malignancies_NNS ,_, and_CC they_PRP are_VBP
        epidemiologically_RB linked_VBN to_TO HIV_NNP ._. Kaposi_NNP sarcoma_NN has_VBZ been_VBN
        reported_VBN in_IN all_DT HIV_NNP risk_NN groups_NNS ._. However_RB ,_, it_PRP occurs_VBZ
        predominantly_RB in_IN homosexual_NN and_CC bisexual_NN men_NNS [_NN 23_CD ]_NN ._. In_IN
        the_DT PIP_NNP study_NN ,_, homosexuality_NN was_VBD not_RB a_DT predominant_NN HIV_NNP risk_NN
        factor_NN ,_, and_CC pulmonary_JJ Kaposi_NNP sarcoma_NN was_VBD diagnosed_VBN in_IN only_RB
        1_CD patient_NN ._.
        Conflicting_NNP evidence_NN links_NNS lung_NN cancer_NN with_IN HIV_NNP
        infection_NN ._. At_IN the_DT beginning_NN of_IN the_DT AIDS_NNP epidemic_NN ,_, few_JJ cases_NNS
        of_IN bronchogenic_JJ carcinoma_NN were_VBD reported_VBN [_NN 24_CD 25_CD ]_NN ._. Using_VBG
        the_DT registry_NN of_IN Bellevue_NNP Hospital_NNP in_IN New_NNP York_NNP City_NNP ,_, Chan_NNP et_CC
        al_NN ._. [_NN 26_CD ]_NN showed_VBD no_DT link_NN between_IN lung_NN cancer_NN and_CC HIV_NNP
        infection_NN ._. Another_DT population-based_JJ study_NN from_IN San_NNP
        Francisco_NNP showed_VBD no_DT excess_NN of_IN lung_NN cancer_NN among_IN a_DT cohort_NN of_IN
        men_NNS with_IN AIDS_NNP [_NN 27_CD ]_NN ._. The_DT Italian_NNP Cooperative_NNP Study_NNP Group_NNP
        described_VBD 19_CD cases_NNS of_IN HIV-associated_NNP lung_NN cancer_NN -_: 16_CD in_IN
        tobacco_NN smokers_NNS [_NN 28_CD ]_NN ._. More_RBR recent_JJ studies_NNS have_VBP indicated_VBN
        an_DT increase_NN in_IN incidence_NN of_IN primary_JJ lung_NN cancer_NN in_IN patients_NNS
        with_IN HIV_NNP infection_NN [_NN 22_CD 29_CD ]_NN ._. Although_IN there_EX was_VBD no_DT case_NN
        of_IN adenocarcinoma_NN in_IN the_DT PIP_NNP study_NN ,_, it_PRP is_VBZ the_DT predominant_NN
        cell_NN type_NN of_IN bronchogenic_JJ carcinoma_NN in_IN patients_NNS with_IN HIV_NNP
        infection_NN [_NN 22_CD 26_CD 30_CD ]_NN ._. The_DT Pulmonary_NNP Complications_NNP of_IN HIV_NNP
        Infection_NNP Study_NNP Group_NNP has_VBZ shown_VBN upper_JJ respiratory_JJ infection_NN
        and_CC bronchitis_NNS to_TO be_VB common_JJ in_IN patients_NNS with_IN HIV_NNP infection_NN
        [_NN 3_CD ]_NN ._. Because_IN the_DT PIP_NNP study_NN included_VBD only_RB hospitalized_VBN
        patients_NNS ,_, minor_JJ respiratory_JJ problems_NNS were_VBD likely_JJ to_TO have_VB
        been_VBN ignored_VBN ._.
        The_DT PIP_NNP study_NN has_VBZ several_JJ limitations_NNS ._. Some_DT important_JJ
        data_NN ,_, such_JJ as_IN smoking_NN history_NN and_CC the_DT use_NN of_IN
        chemoprophylaxis_NNS and_CC antiretroviral_NN drugs_NNS ,_, were_VBD not_RB
        collected_VBN ._. No_DT attempt_NN was_VBD made_VBN to_TO identify_VB patients_NNS with_IN
        pulmonary_JJ hypertension_NN ._. The_DT diagnostic_JJ approaches_NNS varied_VBD
        according_VBG to_TO the_DT patients_NNS '_POS primary_JJ physicians_NNS ._. The_DT
        investigator_NN 's_POS unblinded_JJ review_NN of_IN chest_NN radiographs_NNS may_MD
        have_VB introduced_VBN biases_NNS into_IN the_DT study_NN ._. Diagnostic_NNP
        fiberoptic_JJ bronchoscopy_NN was_VBD performed_VBN in_IN only_RB 69_CD hospital_NN
        admissions_NNS ,_, and_CC thoracotomy_NN and_CC mediastinoscopy_NN were_VBD rarely_RB
        required_VBN ._. This_DT approach_NN may_MD have_VB led_VBN to_TO underdiagnosis_NNS of_IN
        some_DT of_IN the_DT pulmonary_JJ complications_NNS ._. Although_IN MAC_NNP and_CC CMV_NNP
        were_VBD isolated_VBN from_IN the_DT sputum_NN and_CC BAL_NNP of_IN many_JJ patients_NNS ,_, the_DT
        presence_NN of_IN disease_NN could_MD not_RB be_VB ascertained_JJ because_IN
        tissues_NNS were_VBD not_RB available_JJ for_IN examination_NN ._. Because_IN the_DT PIP_NNP
        study_NN was_VBD started_VBN before_IN highly_RB active_JJ antiretroviral_NN
        treatment_NN was_VBD introduced_VBN ,_, the_DT findings_NNS may_MD not_RB apply_VB
        now_RB ._.
      
      
        Conclusions_NNP
        The_DT PIP_NNP study_NN describes_VBZ the_DT nonbacterial_NN pulmonary_JJ
        complications_NNS in_IN 1_CD ,_, 225_CD hospital_NN admissions_NNS of_IN 599_CD patients_NNS
        with_IN HIV_NNP infection_NN ._. The_DT present_JJ data_NN confirm_VBP previously_RB
        described_VBD findings_NNS addressing_VBG these_DT complications_NNS [_NN 2_CD 3_CD 4_CD 5_CD
        6_CD 7_CD ]_NN ,_, [_NN 11_CD 12_CD 13_CD 14_CD 15_CD 22_CD ]_NN ._. With_IN the_DT advent_NN of_IN
        antiretroviral_NN therapy_NN and_CC chemoprophylaxis_NNS against_IN some_DT of_IN
        the_DT opportunistic_JJ infections_NNS ,_, the_DT morbidity_NN and_CC mortality_NN
        of_IN patients_NNS with_IN HIV_NNP infection_NN have_VBP declined_VBN in_IN the_DT last_JJ
        decade_NN ._. The_DT study_NN showed_VBD that_IN PCP_NNP is_VBZ still_RB a_DT frequent_JJ
        complication_NN ,_, despite_IN the_DT availability_NN of_IN chemoprophylaxis_NNS ._.
        Although_IN pulmonary_JJ tissue_NN involvement_NN is_VBZ not_RB confirmed_VBN ,_,
        most_JJS of_IN the_DT patients_NNS with_IN MAC_NNP isolated_VBD from_IN their_PRP$ sputum_NN or_CC
        BAL_NNP have_VBP disseminated_VBN disease_NN ._. These_DT findings_NNS suggest_VBP the_DT
        need_NN for_IN more_RBR effective_JJ preventive_JJ measures_NNS in_IN similar_JJ
        patient_NN populations_NNS ._. The_DT application_NN of_IN highly_RB active_JJ
        antiretroviral_NN treatment_NN and_CC the_DT development_NN of_IN more_JJR
        effective_JJ chemoprophylaxis_NNS against_IN opportunistic_JJ infections_NNS
        are_VBP likely_JJ to_TO be_VB associated_VBN with_IN changes_NNS in_IN the_DT types_NNS and_CC
        severity_NN of_IN pulmonary_JJ complications_NNS that_IN we_PRP see_VBP in_IN these_DT
        patients_NNS ._. The_DT pulmonary_JJ complications_NNS are_VBP also_RB likely_JJ to_TO
        vary_VB according_VBG to_TO geographic_JJ locations_NNS ,_, HIV_NNP risk_NN factor_NN ,_,
        and_CC severity_NN of_IN immunosuppression_NN ._. To_TO keep_VB up_RP with_IN these_DT
        changes_NNS and_CC variations_NNS ,_, we_PRP must_MD continue_VB to_TO monitor_VB and_CC to_TO
        describe_VB the_DT pulmonary_JJ complications_NNS that_WDT develop_VBP in_IN
        patients_NNS with_IN HIV_NNP infection_NN ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
